Quest Diagnostics, Inc. (NYSE: DGX) reported Q4 EPS of $1.19, 13 cents better than the analyst estimate of $1.06. Revenue for the quarter came in at $1.88 billion versus the consensus estimate of $1.86 billion.

Quest Diagnostics, Inc. sees FY2012 EPS of $4.40-$4.55, versus the consensus of $4.66.

For earnings history and earnings-related data on Quest Diagnostics, Inc. (DGX) click here.

Earnings Guidance Hot Guidance